We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.52B
1-Year Est. Return 36.54%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+36.54%
3 Year Est. Return
+184.84%
5 Year Est. Return
+166.78%
10 Year Est. Return
+454.52%
AUM
$1.52B
AUM Growth
+$287M
Cap. Flow
+$202M
Cap. Flow %
13.28%
Top 10 Hldgs %
38.09%
Holding
626
New
199
Increased
41
Reduced
61
Closed
200

Top Buys

Rank Stock Value
1
VISN
Vistance Networks Inc
VISN
+$101M
2
APTV icon
Aptiv
APTV
+$37.5M
3
ACHC icon
Acadia Healthcare
ACHC
+$35.8M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$25.9M
5
BELFA icon
Bel Fuse Inc Class A
BELFA
+$25.1M

Top Sells

Rank Stock Value
1
ENVA icon
Enova International
ENVA
+$49.1M
2
ETH
Grayscale Ethereum Staking Mini ETF Shares
ETH
+$25.8M
3
TRIP icon
TripAdvisor
TRIP
+$10.3M
4
BSOL
Bitwise Solana Staking ETF
BSOL
+$8.47M
5
ATMU icon
Atmus Filtration Technologies
ATMU
+$5.65M

Sector Composition

Rank Sector Weight
1 Technology 19.15%
2 Financials 18.28%
3 Healthcare 14.14%
4 Consumer Discretionary 10.53%
5 Miscellaneous 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHRW icon
151
C.H. Robinson
CHRW
$17.2B
$769K 0.05%
4,084
– –
AHCO icon
152
AdaptHealth
AHCO
$752M
$763K 0.05%
73,219
-91,742
-56% -$1.02M
AKBA icon
153
Akebia Therapeutics
AKBA
$248M
$760K 0.05%
666,954
+291,000
+77% +$346K
ANIP icon
154
ANI Pharmaceuticals
ANIP
$1.7B
$758K 0.05%
9,154
-3,764
-29% -$302K
PGNY icon
155
Progyny
PGNY
$1.95B
$757K 0.05%
+26,258
New +$587K
MKL icon
156
Markel Group
MKL
$21.4B
$756K 0.05%
+387
New +$723K
PSX icon
157
Phillips 66
PSX
$102B
$752K 0.05%
4,447
– –
HTGC icon
158
Hercules Capital
HTGC
$3.18B
$744K 0.05%
+47,148
New +$733K
TRS icon
159
TriMas Corp
TRS
$1.4B
$737K 0.05%
16,365
+1,086
+7% +$43.2K
CORZ icon
160
Core Scientific
CORZ
$5.57B
$733K 0.05%
28,655
-14,806
-34% -$349K
USAU icon
161
US Gold Corp
USAU
$258M
$728K 0.05%
+47,480
New +$751K
ALT icon
162
Altimmune
ALT
$595M
$727K 0.05%
239,280
– –
TAL icon
163
TAL Education Group
TAL
$6.66B
$724K 0.05%
+75,640
New +$795K
LFST icon
164
Lifestance Health
LFST
$4.5B
$712K 0.05%
66,466
-121,244
-65% -$937K
FBRX
165
DELISTED
Forte Biosciences
FBRX
$709K 0.05%
33,346
+7,640
+30% +$181K
SCSC icon
166
Scansource
SCSC
$1.17B
$700K 0.05%
13,432
-6,113
-31% -$268K
ZTS icon
167
Zoetis
ZTS
$29.4B
$694K 0.05%
+9,652
New +$909K
LINE
168
Lineage Inc
LINE
$8.23B
$688K 0.05%
15,910
– –
NSP icon
169
Insperity
NSP
$1.83B
$687K 0.05%
+16,630
New +$545K
POOL icon
170
Pool Corp
POOL
$5.99B
$679K 0.04%
3,159
– –
TBN
171
Tamboran Resources
TBN
$1.22B
$673K 0.04%
+20,688
New +$741K
SPGI icon
172
S&P Global
SPGI
$119B
$669K 0.04%
+1,643
New +$694K
ADT icon
173
ADT
ADT
$4.68B
$668K 0.04%
102,764
+70,547
+219% +$484K
HQY icon
174
HealthEquity
HQY
$7.3B
$668K 0.04%
7,395
-1,403
-16% -$119K
CSTM icon
175
Constellium
CSTM
$3.37B
$666K 0.04%
20,907
+8,823
+73% +$285K
5 6
7
8 9

Similar funds

ACM
Atika Capital Management New York $1.52B AUM 229.41% 1-Year Est. Return
ACM
Adelante Capital Management Alameda, California $1.52B AUM 23.15% 1-Year Est. Return
MIM
Marco Investment Management Atlanta, Georgia $1.52B AUM 47.33% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.52B AUM 10.48% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.52B AUM 3.09% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return

Mangrove Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Mangrove Partners held 626 positions worth $1.52B, up 23% from $1.24B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Mangrove Partners deployed $202M of net new capital in Q2 2026, opening 199 new positions and adding to 41 existing holdings. Its largest new stake was Aptiv: 613,392 shares worth $37.7M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Enova International, an estimated $49.1M trimmed.

  • Mangrove Partners's largest Q2 2026 buy was Aptiv: 613,392 shares worth $37.7M.
  • Mangrove Partners added most to Vistance Networks Inc in Q2 2026, an estimated $101M increase.
  • Mangrove Partners's biggest Q2 2026 reduction was Enova International, cutting an estimated $49.1M.
  • Mangrove Partners fully exited TripAdvisor in Q2 2026, selling an estimated $10.3M.
  • Mangrove Partners's ten largest holdings make up 38% of its $1.52B portfolio in Q2 2026.
  • Mangrove Partners opened 199 new positions and closed 200 in Q2 2026.
  • Mangrove Partners's portfolio value rose 23% quarter-over-quarter to $1.52B.

Based on Mangrove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.